Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells

Abstract excerpt

Mesenchymal stem cells (MSCs) are promising source of cell-based regenerative therapy. In consideration of the risk of allosensitization, autologous MSC-based therapy is preferred over allogenic transplantation in patients with chronic kidney disease (CKD). However, it remains uncertain whether adequate cell functionality is maintained under uremic conditions. As chronic inflammation and oxidative stress in CKD...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epigenetics and DNA Methylation
• Share to Mesenchymal stem cell research
• Share to Metabolism, Diabetes, and Cancer